Skip to main content
. 2021 Feb 1;11:607968. doi: 10.3389/fendo.2020.607968

Figure 1.

Figure 1

Immunocytochemical characterization of transforming growth factor-β (TGF-β)-induced α-smooth muscle actin (α-SMA) expression in Graves’ ophthalmopathy (GO) orbital fibroblasts. Primary cultured GO orbital fibroblasts were stimulated with 3 ng/mL TGF-β1 for 48 h with or without a 1-h pretreatment with different concentrations of simvastatin (1, 5, 10 μM) (A) or ROCK inhibitor Y-27632 (1, 10, 30 μM) (B). α-SMA expression was detected using immunofluorescence staining (green). The bar charts show mean data of relative fluorescence intensity of α-SMA presented as the fold of control. *p < 0.05, **p < 0.01 compared to cells treated with TGF-β1 alone. S = simvastatin; Y = Y-27632.